Oxford Biomedica PLC
2 May 2001
Oxford BioMedica plc ('the Company')
Additional Listing
Application has been made to the UK Listing Authority and the London Stock
Exchange for the admission of 102,900 Ordinary Shares of 1 pence each to
trading on the Official List.
Application will also be made to the UK Listing Authority and London Stock
Exchange for a Block Listing of 17,383,143 Ordinary Shares of 1 pence each in
the Company to be admitted to the Official List. The shares to be issued are
in respect of the Company's share option schemes. Admission is expected to
become effective on 9 May 2001.
The shares, when issued, will rank pari passu in all respects with the
existing ordinary share capital of the company.
Following admission the number of shares in issue of the Company will be
254,820,259.
FURTHER INFORMATION
Andrew Wood, Oxford BioMedica 01865 783000
2 May, 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.